Invest in Transdermal Specialties Global: TSG has created a Patented transdermal Insulin delivery patch for diabetics (both Type 1 & Type 2).

1

Innovative life-sustaining technology providing needle-free drug delivery for diabetes control

2

The team has unique C-Level experience in pharma, biotech, and medical device product develo

3

300 subjects studied in the US and S. Korea. Their blood sugar levels are controlled.

4

300 subjects involved in clinical trials in the US and S. Korea. Only phase 3 is required for FDA

5

The Team has experience in negotiating license and research agreements with Yale Univ., & DuPont

6

The Team has been involved in the commercialization of some of the most iconic Rx and OTC Meds

7

The Team has experience in securing International and Domestic Patents Technologies (>65 issued)

8

The product will improve the quality of life for the over 38M T2 diabetics & 98M Pre-Diabetics in US

Invest in Transdermal Specialties Global